Era chair position for excellent research in oncology
The Biomedical Center of the Faculty of Medicine in Pilsen, which has recently been established at the Charles University with support of the European Fund for Regional Development, represents a high-grade regional research infrastructure in the fundamental field of cancer biology and oncology. However, despite its advanced research and innovation performance, the potential of the Center is still not fully exploited, dominantly due to its unsatisfactory attractiveness to top-class researchers, concerning both established experts as well as promising young scientists and PhD students. This represents a major structural weakness of the Center. To directly address this issue, we propose the Chaperon action with the main goal to recruit a world class researcher and research manager to 1) establish and lead new Laboratory of Translational Cancer Genomics filling a thematic gap in the structure of the Center; 2) become the head of Research Programme 2 of the Center, thus strongly boosting its excellence; and 3) take a position in several institutional advisory and supervisory bodies in order to moderate the transformation of human resource policies and managerial processes at the Faculty of Medicine in Pilsen and Charles University on their way to excellence. Attracting high-quality human resources and assuring their sustainability by bringing the institution in close compliance with the ERA priorities and the Regional Smart Specialisation Strategy, the project will substantially increase the research and innovation (R&I) performance of the Center, provide crucial international networking opportunities with respect to all key stakeholders and increase the competitiveness of the institution in obtaining international funding such as ERC. By achieving these goals, the Chaperon ERA Chairs project will help diminish the inequalities in R&I performance within the ERA.